SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Life Sciences informs about press release

18 Sep 2015 Evaluate

Jubilant Life Sciences has informed about a press release dated September 18, 2015, titled ‘Jubilant Life Sciences receives ANDA approval for Zolmitriptan ODT Tablets’.

The above information is a part of company’s filings submitted to BSE.

Jubilant Pharmova Share Price

952.80 0.10 (0.01%)
30-Jun-2026 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1893.15
Dr. Reddys Labs. 1376.00
Cipla 1454.20
Zydus Lifesciences 1122.00
Lupin 2427.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: